Comparative Analysis of U.S. and Swedish Healthcare Systems: Structural and Policy Implications
Overview
This paper responds to a prior analysis comparing U.S. and Swedish healthcare systems, validating findings on spending disparities and outcomes while proposing deeper structural examination. It argues that the multi-payer U.S. system versus Sweden's single-payer Beveridge model fundamentally explains cost differences, and that fee-for-service incentives drive procedural overuse.
What this essay covers
- Acknowledgment and validation of prior comparative analysis on U.S.-Sweden healthcare spending and outcomes
- Identification of primary cost drivers including high prices, administrative inefficiency, coverage gaps, and social determinants
- Structural analysis of multi-payer versus single-payer systems and their mechanisms for cost control
- Discussion of fee-for-service incentives and procedural overuse as causal factors in excess spending
Preview
Response to Dacia
Dacia, your analysis effectively highlights the stark contrast between US and Swedish healthcare spending and outcomes, accurately citing OECD (2023) data showing U.S. per capita expenditure nearly double Sweden’s despite Sweden’s superior life expectancy and lower infant mortality (OECD, 2023; Schneider et al., 2023). You correctly identify high prices, administrative inefficiency, and coverage gaps as primary drivers of US excess costs (Anderson et al., 2024; Collins et al., 2023), and you appropriately note the role of social determinants and underinvestment in prevention.
One area for deeper exploration is the structural impact of the U.S. multi-payer system versus Sweden’s single-payer Beveridge model, which enables stronger cost control through global budgets and centralized price negotiation (Tikkanen & Abrams, 2020). Additionally, while you mention obesity and injury rates, incorporating evidence on how fee-for-service incentives drive overuse of high-cost procedures would strengthen the causal explanation (Schneider et al., 2023). Overall, your evidence-based policy recommendations align well with successful OECD models.
Excellent work synthesizing complex international comparisons.
References
Anderson, G. F., Hussey, P., & Petrosyan, V. (2024). It’s still the prices: U.S. health spending in international context. Health Affairs, 43(1), 10–18.
Collins, S. R., Gunja, M. Z., & Aboulafia, G. N. (2023). U.S. health insurance coverage and affordability findings from the Commonwealth Fund. The Commonwealth Fund.
OECD. (2023). Health at a Glance 2023: OECD indicators. Organisation for Economic Co-operation and Development.
Schneider, E. C., Shah, A., Doty, M., & Tikkanen, R. (2023). 2023 international comparison of health system performance. The Commonwealth Fund.
Tikkanen, R., & Abrams, M. K. (2020). U.S.